Stockreport

Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc. [Yahoo! Finance]

Candel Therapeutics, Inc.  (CADL) 
PDF Strengthens Company's financial position; enables initiation of phase 3 clinical trial of CAN-2409 in non-small cell lung cancer (NSCLC) Provides non-dilutive capital [Read more]